SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-037183
Filing Date
2023-11-07
Accepted
2023-11-07 07:35:18
Documents
15
Period of Report
2023-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20231107.htm   iXBRL 8-K 33398
2 EX-99.1 bioventusex-991q32023.htm EX-99.1 479536
7 image_0.jpg GRAPHIC 50612
  Complete submission text file 0001628280-23-037183.txt   781572

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20231107.xsd EX-101.SCH 2157
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bvs-20231107_def.xml EX-101.DEF 15409
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20231107_lab.xml EX-101.LAB 29868
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20231107_pre.xml EX-101.PRE 16123
9 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20231107_htm.xml XML 2919
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

IRS No.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 231381595
SIC: 3841 Surgical & Medical Instruments & Apparatus